Viewing Study NCT02837757


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-01-04 @ 11:09 AM
Study NCT ID: NCT02837757
Status: TERMINATED
Last Update Posted: 2022-05-16
First Post: 2016-07-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module